scholarly journals A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells

2017 ◽  
Vol 8 (1) ◽  
Author(s):  
Tetsuro Yoshimaru ◽  
Masaya Ono ◽  
Yoshimi Bando ◽  
Yi-An Chen ◽  
Kenji Mizuguchi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Anchoring Protein ◽  
Oestrogen Signalling

scholarly journals Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells

2011 ◽  
Vol 11 (7) ◽  
pp. 523-532 ◽  
Author(s):  
John J. Tyson ◽  
William T. Baumann ◽  
Chun Chen ◽  
Anael Verdugo ◽  
Iman Tavassoly ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Cell Fate ◽  
Breast Cancer Cells ◽  
Dynamic Modelling ◽  
Oestrogen Signalling

scholarly journals Role of sphingolipids in oestrogen signalling in breast cancer cells: an update

2013 ◽  
Vol 220 (3) ◽  
pp. R25-R35 ◽  
Author(s):  
O Sukocheva ◽  
C Wadham
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Second Messengers ◽  
Membrane Receptors ◽  
Future Research ◽  
Specific Effects ◽  
Oestrogen Signalling ◽  
Signalling Cascade

The signaling pathways activated by the steroid hormone oestrogen include a variety of cytoplasmic second messengers linked to a multitude of tissue-specific effects. In the last decade, sphingolipids and their membrane receptors were added to the list of oestrogen-activated mediators. Oestrogen triggers the sphingolipid signalling cascade in various tissues including breast cancer. Extensive research has shown that sphingolipids are the key regulatory molecules in growth factor networks. Sphingolipids can control the rate of cell proliferation and the differentiation outcome during malignant transformation. In this study, we summarise novel experimental evidences linking sphingolipids to oestrogen-activated effects, highlight the role of sphingolipids in cancer cells and discuss new avenues for future research at the intersection between oestrogen and sphingolipid signalling.

The proliferation of breast cancer cells are inhibited by the human intrabody targeting cyclinD1

2010 ◽  
Vol 34 (8) ◽  
pp. S49-S49
Author(s):  
Lei Wang ◽  
Xun Zhou ◽  
Lihong Zhou ◽  
Yong Chen ◽  
Xun Zhu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells

Asperjinone, a norneolignan, and terrein, a suppressor of ABCG2-expressing breast cancer cells, from Aspergillus terreus

Planta Medica ◽  
2012 ◽  
Vol 78 (11) ◽  
Author(s):  
WY Liao ◽  
CN Shen ◽  
LH Lin ◽  
YL Yang ◽  
HY Han ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Aspergillus Terreus
Sign in / Sign up

Export Citation Format

Share Document